000 01392 a2200409 4500
005 20250516203608.0
264 0 _c20151012
008 201510s 0 0 eng d
022 _a1473-1150
024 7 _a10.1038/tpj.2014.12
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGassó, P
245 0 0 _aEffect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients.
_h[electronic resource]
260 _bThe pharmacogenomics journal
_cOct 2014
300 _a457-62 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650 0 4 _aATP Binding Cassette Transporter, Subfamily B
_xgenetics
650 0 4 _aAdolescent
650 0 4 _aChild
650 0 4 _aCytochrome P-450 CYP2C9
_xgenetics
650 0 4 _aCytochrome P-450 CYP2D6
_xgenetics
650 0 4 _aFemale
650 0 4 _aFluoxetine
_xblood
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aMale
700 1 _aRodríguez, N
700 1 _aMas, S
700 1 _aPagerols, M
700 1 _aBlázquez, A
700 1 _aPlana, M T
700 1 _aTorra, M
700 1 _aLázaro, L
700 1 _aLafuente, A
773 0 _tThe pharmacogenomics journal
_gvol. 14
_gno. 5
_gp. 457-62
856 4 0 _uhttps://doi.org/10.1038/tpj.2014.12
_zAvailable from publisher's website
999 _c23671112
_d23671112